Company: TVRD
Filing Date: 2025-05-13
Form Type: 10-Q
Source: 0001558370-25-007575
Chunk: 1

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-05-13
Form: 10-Q
Item: Item 1
Chunk 1
---
Item 1.Financial Statements.

TVARDI THERAPEUTICS, INC.

(Formerly Cara Therapeutics, Inc.)

CONDENSED CONSOLIDATED BALANCE SHEETS

(amounts in thousands, excluding share and per share data)

(unaudited)

​​​​​​​​​​​​​​​    March 31, 2025    December 31, 2024Assets ​​ ​  Current assets: ​   ​  Cash and cash equivalents​$ 34,217​$ 37,903Accounts receivable, net - related party​​ 1,229​​ 407Inventory, net​​ 900​​ 900Other receivables​  1,009​  4,088Prepaid expenses​  1,592​  529Total assets​$ 38,947​$ 43,827Liabilities and stockholders’ equity​ ​​   Current liabilities:​  ​​   Accounts payable and accrued expenses​$ 1,199​$ 3,972Total current liabilities​  1,199​  3,972​​​​​​​Liability related to sales of future royalties and milestones, net​​ 45,821​​ 44,448Total liabilities​  47,020​  48,420Commitments and contingencies (Note 16)​  —​  —Stockholders’ equity:​  ​​   Preferred stock; $0.001 par value; 5,000,000 shares authorized at March 31, 2025 and December 31, 2024, zero shares issued and outstanding at March 31, 2025 and December 31, 2024​  —​  —Common stock; $0.001 par value; 16,666,667 shares authorized at March 31, 2025 and December 31, 2024, 1,524,535 shares and 1,523,743 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively​  2​  2Additional paid-in capital​  752,443​  751,017Accumulated deficit​  (760,518)​  (755,612)Accumulated other comprehensive loss​  —​  —Total stockholders’ equity​  (8,073)​  (4,593)Total liabilities and stockholders